rolipram has been researched along with Alcohol Drinking in 6 studies
Alcohol Drinking: Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Using three rodent models of ethanol abstinence, we examined the effects of rolipram, a prototypical, selective PDE4 inhibitor, on (1) anxiety-like behavior induced by repeated ethanol abstinence in the elevated plus maze test in fawn-hooded (FH/Wjd) rats, (2) anxiety-like behavior in the open-field test and light-dark transition test following acute ethanol abstinence in C57BL/6J mice, and (3) anxiety- and depressive-like behavior induced by protracted ethanol abstinence in the elevated plus maze, forced-swim, and tail-suspension tests in C57BL/6J mice." | 7.85 | Attenuation of ethanol abstinence-induced anxiety- and depressive-like behavior by the phosphodiesterase-4 inhibitor rolipram in rodents. ( Fei, N; Gong, MF; Liang, JH; Pan, JC; Wen, RT; Xu, JP; Xu, Y; Zhang, HT; Zhou, YM, 2017) |
| "Gabapentin increased ethanol (EtOH) binge-like alcohol drinking in female HDID-1 and HS/NPT mice." | 3.96 | Effects of Pharmacologically Targeting Neuroimmune Pathways on Alcohol Drinking in Mice Selectively Bred to Drink to Intoxication. ( Blednov, YA; Crabbe, JC; Metten, P; Ozburn, AR; Potretzke, S; Townsley, KG, 2020) |
| "Using three rodent models of ethanol abstinence, we examined the effects of rolipram, a prototypical, selective PDE4 inhibitor, on (1) anxiety-like behavior induced by repeated ethanol abstinence in the elevated plus maze test in fawn-hooded (FH/Wjd) rats, (2) anxiety-like behavior in the open-field test and light-dark transition test following acute ethanol abstinence in C57BL/6J mice, and (3) anxiety- and depressive-like behavior induced by protracted ethanol abstinence in the elevated plus maze, forced-swim, and tail-suspension tests in C57BL/6J mice." | 3.85 | Attenuation of ethanol abstinence-induced anxiety- and depressive-like behavior by the phosphodiesterase-4 inhibitor rolipram in rodents. ( Fei, N; Gong, MF; Liang, JH; Pan, JC; Wen, RT; Xu, JP; Xu, Y; Zhang, HT; Zhou, YM, 2017) |
| "Exp 1 determined the dose-response effects of PDE4 inhibitors, rolipram, and Ro 20-1724, on 2 h/day free-choice EtOH intake by adult P and HAD1 rats." | 1.42 | Reduction of alcohol drinking of alcohol-preferring (P) and high-alcohol drinking (HAD1) rats by targeting phosphodiesterase-4 (PDE4). ( Bell, RL; Ding, ZM; Franklin, KM; Hauser, SR; Lasek, AW; McBride, WJ; McClintick, J, 2015) |
| "Alcohol dependence is a complex psychiatric disorder demanding development of novel pharmacotherapies." | 1.38 | The phosphodiesterase-4 (PDE4) inhibitor rolipram decreases ethanol seeking and consumption in alcohol-preferring Fawn-Hooded rats. ( Lawrence, AJ; Liang, JH; Liu, Q; Qin, WJ; Wang, WP; Wen, RT; Zhang, HT; Zhang, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ozburn, AR | 1 |
| Metten, P | 1 |
| Potretzke, S | 1 |
| Townsley, KG | 1 |
| Blednov, YA | 1 |
| Crabbe, JC | 1 |
| Liu, X | 1 |
| Hao, PD | 1 |
| Yang, MF | 1 |
| Sun, JY | 1 |
| Mao, LL | 1 |
| Fan, CD | 1 |
| Zhang, ZY | 1 |
| Li, DW | 1 |
| Yang, XY | 1 |
| Sun, BL | 1 |
| Zhang, HT | 4 |
| Gong, MF | 1 |
| Wen, RT | 2 |
| Xu, Y | 1 |
| Pan, JC | 1 |
| Fei, N | 1 |
| Zhou, YM | 1 |
| Xu, JP | 1 |
| Liang, JH | 2 |
| Franklin, KM | 1 |
| Hauser, SR | 1 |
| Lasek, AW | 1 |
| McClintick, J | 1 |
| Ding, ZM | 1 |
| McBride, WJ | 1 |
| Bell, RL | 1 |
| Hu, W | 1 |
| Lu, T | 1 |
| Chen, A | 1 |
| Huang, Y | 1 |
| Hansen, R | 1 |
| Chandler, LJ | 1 |
| Zhang, M | 1 |
| Qin, WJ | 1 |
| Liu, Q | 1 |
| Wang, WP | 1 |
| Lawrence, AJ | 1 |
6 other studies available for rolipram and Alcohol Drinking
| Article | Year |
|---|---|
Effects of Pharmacologically Targeting Neuroimmune Pathways on Alcohol Drinking in Mice Selectively Bred to Drink to Intoxication.
Topics: Alcohol Drinking; Alcoholic Intoxication; Alkanesulfonates; Animals; Binge Drinking; Dose-Response R | 2020 |
The phosphodiesterase-4 inhibitor roflumilast decreases ethanol consumption in C57BL/6J mice.
Topics: Alcohol Drinking; Aminopyridines; Animals; Benzamides; Cyclic Nucleotide Phosphodiesterases, Type 4; | 2017 |
Attenuation of ethanol abstinence-induced anxiety- and depressive-like behavior by the phosphodiesterase-4 inhibitor rolipram in rodents.
Topics: Alcohol Abstinence; Alcohol Drinking; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; | 2017 |
Reduction of alcohol drinking of alcohol-preferring (P) and high-alcohol drinking (HAD1) rats by targeting phosphodiesterase-4 (PDE4).
Topics: Alcohol Drinking; Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, | 2015 |
Inhibition of phosphodiesterase-4 decreases ethanol intake in mice.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Alcohol Drinking; Animals; Brain; Central Nervous Sy | 2011 |
The phosphodiesterase-4 (PDE4) inhibitor rolipram decreases ethanol seeking and consumption in alcohol-preferring Fawn-Hooded rats.
Topics: Alcohol Deterrents; Alcohol Drinking; Alcoholism; Animals; Disease Models, Animal; Dose-Response Rel | 2012 |